No Data
No Data
No Data
No Data
No Data
Peak Bio's Strategic Merger With Akari Therapeutics
TipRanksMar 6 06:03
Shareholder Alert: Ademi LLP Investigates Whether Peak Bio Inc. Has Obtained a Fair Price in Its Transaction With Akari
MILWAUKEE, March 5, 2024 /PRNewswire/ -- Ademi LLP is investigating Peak Bio (OTC: PKBO) for possible breaches of fiduciary duty and other violations of law in its transaction with Akari. Click here
PR NewswireMar 6 01:27
Akari Therapeutics Rises on All Stock Deal With Peak Bio
Seeking AlphaMar 5 23:08
Peak Stockholders Will Receive a Number of Akari Ordinary Shrs for Each Shr of Peak Stk They Own >AKTX
Peak Stockholders Will Receive a Number of Akari Ordinary Shrs for Each Shr of Peak Stk They Own >AKTX
Dow JonesMar 5 21:05
Akari Therapeutics, Peak Bio: Hoyoung Huh, M.D., Ph.D. Expected to Serve as Chairman of Combined Entity >AKTX
Akari Therapeutics, Peak Bio: Hoyoung Huh, M.D., Ph.D. Expected to Serve as Chairman of Combined Entity >AKTX
Dow JonesMar 5 21:04
Akari Therapeutics, Peak Bio: Post-merger Bd of Directors Will Consist of 3 Directors Selected by Each Co and 1 Independent Director Jointly Selected >AKTX
Akari Therapeutics, Peak Bio: Post-merger Bd of Directors Will Consist of 3 Directors Selected by Each Co and 1 Independent Director Jointly Selected >AKTX
Dow JonesMar 5 21:04
No Data
No Data